Clinical Development Lead, Transplant Expansion / New Indications
Biogen- Full Time
- Senior (5 to 8 years)
Candidates should possess relevant qualifications in the field of biotechnology or a related area. Experience in clinical development and gene therapy is preferred, along with a commitment to inclusion and diversity in the workplace.
The role involves submitting resumes for future consideration for various positions within Adverum Biotechnologies, Inc. Employees will participate in company equity incentive award plans and standard employee benefit programs.
Decodes immune cell genetic information for diagnostics
Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand the immune response to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies uses advanced data algorithms to analyze immune cell genetics and generates revenue through partnerships with pharmaceutical companies, licensing technology, and offering diagnostic services. Their goal is to leverage immune system data to advance healthcare and develop effective therapies for various diseases.